Oncology Institute Q2 FY26 net loss narrows 42.4% to $9.79 million; revenue rises 34.6% to $161.28 million - TOI News | RalliesOncology Institute Q2 FY26 net loss narrows 42.4% to $9.79 million; revenue rises 34.6% to $161.28 million
T
TOI• Quarterly results
- The Oncology Institute posted a GAAP net loss of $9.79 million for the quarter ended June 30, 2026, narrowing from $17.01 million a year earlier.
- Revenue climbed 34.6% to $161.28 million, driven by specialty pharmacy up 57.6% to $98.61 million.
- Patient services revenue rose 5.3% to $58.83 million, as capitation gains were partially offset by lower fee-for-service activity.
- Adjusted EBITDA swung to a gain of $229,000 from a loss of $4.09 million, as SG&A fell 3.9 percentage points to 18.6% of revenue.
•
